A Resource for Healthcare and Social Services Professionals
September 20, 2021
8:00 am–12:00 pm ET
This two-part training is intended to provide eight hours of required training for providers seeking their buprenorphine waivers.
This eight-hour course prepares physicians, nurse practitioners, and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine to over 30 patients for Physicians. Advanced Practice Providers must complete 24 hours of specialized training to prescribe buprenorphine to over 30 patients.
Physicians (MD, DO), Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants
Simeon Kimmel is an Assistant Professor of Medicine at Boston University School of Medicine and an Attending Physician in the Sections of General Internal Medicine and Infectious Diseases at Boston Medical Center and Medical Director of Project TRUST, Boston Medical Center’s harm reduction focused drop-in center. He trained in Internal Medicine and Primary Care at Brigham and Women’s Hospital before completing a joint fellowship in Addiction Medicine and Infectious Diseases at Boston Medical Center. He also earned a Master’s Degree in Medical Anthropology from the Harvard Graduate School of Arts and Sciences. His research focuses on improving retention in treatment with medications for opioid use disorder following serious injection related infections as well as the integration of addiction and harm reduction services with infectious disease care. He was awarded a Career Development Award from NIDA in 2021.Rossana Lau-Ng
MD, MBA, CMD
Dr. Lau-Ng is a graduate of Tufts University School of Medicine combined MD/MBA program in Health Management. She completed her Family Medicine and Community Health residency at University of Massachusetts Medical School, and then went on to complete a 2-year Geriatric Medicine clinician-educator track fellowship at Boston University School of Medicine/Boston Medical Center.
As an attending physician in the Section of Geriatrics at Boston Medical Center, she sees patients in local area skilled nursing facilities, providing care for subacute rehabilitation patients and long-term care residents. She is the medical director of the Nursing Home Program in the Section of Geriatrics, and the medical director of the Decanter Program at Boston Medical Center working with an interprofessional committee on care transitions of un-/underinsured patients from the hospital to appropriate post-acute care facilities.Annie Potter
MSN, MPH, NP, CARN-AP
Annie is a Nurse Practitioner at Boston Medical Center and Assistant Professor of Medicine at Boston University School of Medicine. Annie educates and supports health care providers on best practices in the treatment of substance use disorders and serves as the Medical Director for the Massachusetts Office Based Addiction Treatment ECHO. Prior to joining BMC, Annie practiced at a community health center in Baltimore, MD, where she established and served as the clinical lead for the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned her Masters of Nursing and Masters of Public Health from the Johns Hopkins School of Nursing and Bloomberg School of Public Health, respectively.
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
For more information, visit www.pcssNOW.org
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health , the Bureau of Substance Abuse Services and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the healthcare team.
In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA), Association for Social Work Boards (ASWB) and American Dental Association (ADA).
Interprofessional Continuing Education (IPCE) Designation Statement: This activity was planned by and for the healthcare team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP's Joint Accreditation provider #4008192. This program is approved for up to 8 Nursing Contact Hours.
PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.